 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || HEC68498 / HEC Pharm
Trial completion, Metastases: Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors (clinicaltrials.gov) - Aug 12, 2022
P1, N=12, Completed, Sponsor: Sunshine Lake Pharma Co., Ltd.
Active, not recruiting --> Completed
- || HEC68498 / HEC Pharm
Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date, Metastases: Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors (clinicaltrials.gov) - May 6, 2022
P1, N=12, Active, not recruiting, Sponsor: Sunshine Lake Pharma Co., Ltd.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=72 --> 12 | Trial completion date: Oct 2021 --> Dec 2022 | Trial primary completion date: Feb 2021 --> Jun 2022
- ||| HEC68498 / HEC Pharm
Trial completion: The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects (clinicaltrials.gov) - May 7, 2021
P1, N=55, Completed, Sponsor: Sunshine Lake Pharma Co., Ltd.
Recruiting --> Active, not recruiting | N=72 --> 12 | Trial completion date: Oct 2021 --> Dec 2022 | Trial primary completion date: Feb 2021 --> Jun 2022 Active, not recruiting --> Completed
- || HEC68498 / HEC Pharm
Enrollment closed, Trial completion date: The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects (clinicaltrials.gov) - Mar 22, 2021
P1, N=55, Active, not recruiting, Sponsor: Sunshine Lake Pharma Co., Ltd.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Mar 2019 --> Mar 2022
- ||| HEC68498 / HEC Pharm
New P1 trial, Metastases: Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors (clinicaltrials.gov) - Mar 26, 2020
P1, N=72, Recruiting, Sponsor: Sunshine Lake Pharma Co., Ltd.
- | HEC68498 / HEC Pharm
Enrollment open: The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects (clinicaltrials.gov) - Sep 7, 2018
P1, N=72, Recruiting, Sponsor: Sunshine Lake Pharma Co., Ltd.
Recruiting --> Active, not recruiting | Trial completion date: Mar 2019 --> Mar 2022 Not yet recruiting --> Recruiting
- ||| HEC68498 / HEC Pharm
New P1 trial: The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects (clinicaltrials.gov) - Apr 18, 2018
P1, N=72, Not yet recruiting, Sponsor: Sunshine Lake Pharma Co., Ltd.